Vita Medical blood purification production base phase II approved in Guangzhou

Vita Medical Products (Guangzhou) Co., Ltd. received approval for phase II of its blood purification product R&D and production base in Zengcheng, Guangzhou, with a total investment of 400 million yuan and expected annual output value of 500 million yuan.

“维泰医疗血液净化产品研发生产基地项目二期于11月4日复核通过，状态为办结（通过）。”guandian.cn

• 1 source
• guandian.cn维泰医疗血液净化生产基地项目二期获批 总投资4亿元 - 观点网Nov 4, 2026

Summarized from public sources; check the original articles before acting on it.